ISE Chemicals Corporation
ICHMF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $11,047 | $8,235 | $8,688 | $9,265 |
| % Growth | 34.1% | -5.2% | -6.2% | – |
| Cost of Goods Sold | $7,407 | $5,577 | $6,191 | $6,256 |
| Gross Profit | $3,640 | $2,658 | $2,497 | $3,009 |
| % Margin | 33% | 32.3% | 28.7% | 32.5% |
| R&D Expenses | $0 | $0 | $306 | $0 |
| G&A Expenses | $0 | $0 | -$94 | $0 |
| SG&A Expenses | $807 | $657 | $271 | $638 |
| Sales & Mktg Exp. | $0 | $0 | $365 | $0 |
| Other Operating Expenses | $0 | $0 | $38 | $0 |
| Operating Expenses | $807 | $657 | $615 | $638 |
| Operating Income | $2,833 | $2,001 | $1,882 | $2,371 |
| % Margin | 25.6% | 24.3% | 21.7% | 25.6% |
| Other Income/Exp. Net | -$57 | -$101 | -$91 | -$54 |
| Pre-Tax Income | $2,776 | $1,900 | $1,791 | $2,317 |
| Tax Expense | $820 | $538 | $536 | $748 |
| Net Income | $1,955 | $1,362 | $1,255 | $1,570 |
| % Margin | 17.7% | 16.5% | 14.4% | 16.9% |
| EPS | 383.63 | 267.27 | 246.35 | 3.08 |
| % Growth | 43.5% | 8.5% | 7,898.4% | – |
| EPS Diluted | 383.63 | 267.27 | 246.35 | 3.08 |
| Weighted Avg Shares Out | 5 | 5 | 5 | 510 |
| Weighted Avg Shares Out Dil | 5 | 5 | 5 | 510 |
| Supplemental Information | – | – | – | – |
| Interest Income | $6 | $2 | $4 | $3 |
| Interest Expense | $0 | $0 | $0 | $1 |
| Depreciation & Amortization | $0 | $487 | $494 | $498 |
| EBITDA | $2,776 | $2,390 | $2,375 | $2,817 |
| % Margin | 25.1% | 29% | 27.3% | 30.4% |